Your session is about to expire
← Back to Search
Mindfulness for Breast Cancer
N/A
Waitlist Available
Led By Lisa Golman-Rosas, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 year
Awards & highlights
Study Summary
This trial is testing a mindfulness program to see if it can help Latina breast cancer patients with anxiety and depression.
Who is the study for?
This trial is for Spanish-speaking Latinas who have had breast cancer treatment or endocrine therapy in the last year. They must identify as having anxiety, depression, or sleep disturbances and be able to sign consent. It's not for those with other diagnoses besides invasive breast cancer, non-Spanish speakers, certain mental health conditions, inability to attend sessions, or current participation in similar programs.Check my eligibility
What is being tested?
The study tests a mindfulness program translated into Spanish and delivered by a trained community health worker. Its cultural acceptability and feasibility are evaluated alongside its effectiveness at reducing anxiety and depression among Latina breast cancer patients.See study design
What are the potential side effects?
Since this trial involves a mindfulness program rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing personal experiences during group sessions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through study completion, an average of 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability change across session
Difference in Feasibility
Secondary outcome measures
Differences in Center for Epidemiological Studies-Depression (CES-D) between time points.
Differences in Generalized Anxiety Disorder-7 (GAD7) between time points.
Differences in PROMIS-SD between time points
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Mindfulness group visitActive Control1 Intervention
Participants will attend 6 weekly educational and mindfulness sessions
Group II: Wait list controlPlacebo Group1 Intervention
Participants will be placed on a wait list
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,387 Previous Clinical Trials
17,334,019 Total Patients Enrolled
60 Trials studying Breast Cancer
111,149 Patients Enrolled for Breast Cancer
Maria G Juarez-Reyes, MD, PhDStudy DirectorStanford University
Lisa Golman-Rosas, PhDPrincipal InvestigatorStanford University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot attend group sessions due to physical or psychological reasons.I am a cancer survivor not currently on any active or hormone therapy.I am currently participating in a stress reduction or mindfulness program.I have been treated for breast cancer in the last 12 months.I have been diagnosed with bipolar disorder or a psychotic disorder.I have not had breast cancer treatment or hormone therapy in the last year.I have a breast condition but it's not invasive breast cancer.I do not speak Spanish.You have told the researchers that you have anxiety, depression, or trouble sleeping.
Research Study Groups:
This trial has the following groups:- Group 1: Mindfulness group visit
- Group 2: Wait list control
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for patients to still participate in this clinical investigation?
"As per information on clinicaltrials.gov, the current recruitment period for this trial has ended as of June 21st 2022. Despite it no longer being open to enrollment, 2819 other trials are presently recruiting participants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger